Moreover, confocal and flow cytometry analyses revealed that the P21 treatment group showed markedly amplified tumor-infiltrating CD8+ T cells in the TME (Figure 3K) and increased proportions of CD8+ T cells (CD45.2+CD3+CD8+; Figure 3L and S3G). This evidence concerns the gene CD8A and neoplasm.